Skip to main content
All lobbying clients

GILEAD SCIENCES, INC.

Lobbying client · California · filed 2025 to 2026

A Life-Science Company advancing therapies against life-threatening diseases

$18,102,000 Reported spend
79 Filings counted
13 Outside firms hired
8 Bills named

Spend is reported income plus in-house expenses across 79 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 14 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as GILEAD SCIENCES INC, GILEAD SCIENCES INC.

 Who filed for this client 14

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 8
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    8 filings
  • HR 5376
    Impacts and Outcomes for Health Career Training Act
    6 filings
  • S 998
    Medical Supply Chain Resiliency Act
    4 filings
  • HR 2213
    Medical Supply Chain Resiliency Act
    3 filings
  • HR 1
    One Big Beautiful Bill Act
    2 filings
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    2 filings
  • S 839
    Safeguarding Honest Speech Act
    2 filings
  • S 832
    EPIC Act of 2025
    1 filing
 Reported by year 2 years
  • 2026 $6,650,000 26 filings
  • 2025 $11,452,000 53 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 17
  • HOUSE OF REPRESENTATIVES 72
  • SENATE 66
  • Health & Human Services, Dept of (HHS) 19
  • White House Office 14
  • Centers For Medicare and Medicaid Services (CMS) 12
  • Centers For Disease Control & Prevention (CDC) 6
  • Commerce, Dept of (DOC) 6
  • Executive Office of the President (EOP) 6
  • Food & Drug Administration (FDA) 6
  • Natl Institutes of Health (NIH) 6
  • Office of Management & Budget (OMB) 6
  • Patent & Trademark Office (PTO) 6
  • State, Dept of (DOS) 6
  • Treasury, Dept of 6
  • U.S. Trade Representative (USTR) 6
  • Office of Science & Technology Policy (OSTP) 1
  • Office of the Vice President of the United States 1
 Recent filings 80 total
Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026
View →
Q2 report
TODD STRATEGY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026
View →
Q2 report
FORBES-TATE
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 income · posted Jul 20, 2026
View →
Q2 report
GILEAD SCIENCES, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $1,590,000 expenses · posted Jul 20, 2026
View →
Q2 report
W STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · $60,000 income · posted Jul 20, 2026
View →
Q2 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $75,000 income · posted Jul 20, 2026
View →
Q2 report
MILLER STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · $150,000 income · posted Jul 20, 2026
View →
Q2 report
THE MCMANUS GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
FARRAGUT PARTNERS LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026
View →
Q2 report
THE DUBERSTEIN GROUP INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · $90,000 income · posted Jul 20, 2026
View →
Q2 report
TIBER CREEK GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 18, 2026
View →
Q2 report
CAPITOL TAX PARTNERS, LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 16, 2026
View →
Q2 report
EMPIRE CONSULTING GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 16, 2026
View →
Q1 report
TIBER CREEK GROUP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View →
Q1 report
THE MCMANUS GROUP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View →
Q1 report
THE DUBERSTEIN GROUP INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · $90,000 income · posted Apr 20, 2026
View →
Q1 report
TARPLIN, DOWNS & YOUNG, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 20, 2026
View →
Q1 report
TODD STRATEGY GROUP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 20, 2026
View →
Q1 report
GILEAD SCIENCES, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $3,190,000 expenses · posted Apr 20, 2026
View →
Q1 report
W STRATEGIES, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · $60,000 income · posted Apr 20, 2026
View →

Showing the 20 most recent of 80 filings. Search the explorer for "GILEAD SCIENCES, INC.".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem